Back
Ascendis Pharma AS Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
ASND
Ascendis Pharma AS
Last Price:
$155.54
Seasonality Move:
-2.92%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Ascendis Pharma AS Stock Forecast
-
Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 31.1% based on the past 10 years of stock performance.
-
Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Ascendis Pharma AS Stock Undervalued?The current Ascendis Pharma AS [ASND] share price is $157.94. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ascendis Pharma AS Stock Go Up Next Year?
-
Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 31.1% based on the past 10 years of stock performance.
Ascendis Pharma AS Stock Rating
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS overpriced?
-
Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Ascendis Pharma AS Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com
52-Week Data
52-Week High:
169.37
52-Week Low:
111.09
Prediction Charts
Market Cap:
9.5B
Price in USD:
157.94
Volume:
265K
Beta:
0.62
Technical Analysis
SMA50:
143.05
SMA100:
137.33
SMA200:
135.67
52-Wk Change:
6.4%
Stock Predictions
-
Is Ascendis Pharma AS stock public?Yes, Ascendis Pharma AS is a publicly traded company.
-
What is the Ascendis Pharma AS stock quote today?The Ascendis Pharma AS stock price is 157.94 USD today.
-
How to buy Ascendis Pharma AS stock online?You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-7 | 151.03 | 145.74 | 152.41 | 144.75 |
| Mar-11 | 137.90 | 145.63 | 145.97 | 136.57 |
| Mar-12 | 147.64 | 150.31 | 150.80 | 146.05 |
| Mar-13 | 150.20 | 152.31 | 153.50 | 148.57 |
| Mar-14 | 153.00 | 152.98 | 155.39 | 151.22 |
| Mar-17 | 157.90 | 168.84 | 169.37 | 157.59 |
| Mar-18 | 168.01 | 164.65 | 168.97 | 163.93 |
| Mar-19 | 164.29 | 166.05 | 166.86 | 161.01 |
| Mar-20 | 164.72 | 163.24 | 165.74 | 162.71 |
| Mar-21 | 161.99 | 165.99 | 168.40 | 161.50 |
| Mar-24 | 165.83 | 167.99 | 169.00 | 165.35 |
| Mar-25 | 167.36 | 161.04 | 167.70 | 161.04 |
| Mar-26 | 159.81 | 158.28 | 161.43 | 157.61 |
| Mar-27 | 158.47 | 157.94 | 161.91 | 157.01 |
Ascendis Pharma AS Earnings
Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ascendis Pharma AS Forecast Revenue Growth
Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.04 per share, an increase this year of $3.20 per share, and an increase next year of $5.33 per share.
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.